Presentation is loading. Please wait.

Presentation is loading. Please wait.

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Published byBasil McKenzie Modified over 6 years ago

Similar presentations

Presentation on theme: "Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data."— Presentation transcript:

1 Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry  Rachel Lampert, MD, Yongfei Wang, MS, Jeptha P. Curtis, MD  American Heart Journal  Volume 165, Issue 6, Pages e2 (June 2013) DOI: /j.ahj Copyright © 2013 Mosby, Inc. Terms and Conditions

2 Figure 1 Timeline depicting model families available at the start of the analysis period and those released during the analysis period. American Heart Journal  , e2DOI: ( /j.ahj ) Copyright © 2013 Mosby, Inc. Terms and Conditions

3 Figure 2 Hospital variation in use of “previously released” devices.
American Heart Journal  , e2DOI: ( /j.ahj ) Copyright © 2013 Mosby, Inc. Terms and Conditions

4 Figure 3 Physician variation in use of previously released devices.
American Heart Journal  , e2DOI: ( /j.ahj ) Copyright © 2013 Mosby, Inc. Terms and Conditions

5 Figure 4 Correlation of physician use of “previously released” devices between hospitals. Each point represents the correlation between hospitals for 1 physician of the 174 physicians performing at least 10 implants at each of 2 hospitals. R2 value for the correlation was 0.25, P < .001. American Heart Journal  , e2DOI: ( /j.ahj ) Copyright © 2013 Mosby, Inc. Terms and Conditions

Download ppt "Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data."

Similar presentations

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.
The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.

The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Variation in Use of Dual-Chamber Implantable Cardioverter-Defibrillators:

Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Variation in Use of Dual-Chamber Implantable Cardioverter-Defibrillators:
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial  Bruce.

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial  Bruce.
An Early Look at Performance on the Emergency Care Measures Included in Medicare's Hospital Inpatient Value-Based Purchasing Program  Megan McHugh, PhD,

An Early Look at Performance on the Emergency Care Measures Included in Medicare's Hospital Inpatient Value-Based Purchasing Program  Megan McHugh, PhD,
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
Downstream coronary effects of drug-eluting stents

Downstream coronary effects of drug-eluting stents
Tell-tale Telangiectasias

Tell-tale Telangiectasias
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.
Colloquium on Therapy of Right Heart Failure

Colloquium on Therapy of Right Heart Failure
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.
American Heart Journal

American Heart Journal
Severe Tuberculosis Sepsis in an Immunocompetent Patient

Severe Tuberculosis Sepsis in an Immunocompetent Patient

Similar presentations

Ads by Google